RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
McKesson Europe Stock

McKesson Europe ROCE 2024

McKesson Europe ROCE

0.02

Ticker

CLS1.HM

ISIN

DE000CLS1001

WKN

CLS100

In 2024, McKesson Europe's return on capital employed (ROCE) was 0.02, a -50.84% increase from the 0.03 ROCE in the previous year.

McKesson Europe Aktienanalyse

What does McKesson Europe do?

The McKesson Europe AG is one of the largest pharmacy and pharmaceutical trading chains in Europe and has its roots in the USA. The company was founded in 1833 by John McKesson in New York City and initially focused on the sale of medical equipment and drugs for hospitals. Since then, the company has continuously evolved and expanded. In 2007, the company merged with the German Celesio AG and subsequently operated under the name McKesson Europe AG. The company now operates with over 1,500 pharmacies in more than 15 countries and employs over 39,000 people worldwide. The business model of McKesson Europe AG focuses on the distribution of medications and health and beauty products. The company's strategy is to offer a wide range of products and services to pharmacies, consumers, and clinics. The company is divided into various business segments. Prominent examples of these business segments are wholesale and pharmaceutical manufacturing, as well as involvement in online retail, consulting services for pharmacists and clinics, and the company is also an Apple OEP contractor. The wholesale division of McKesson Europe AG is one of the largest in Europe and supplies pharmacies, clinics, and specialized retailers throughout Europe. The company relies on efficient logistics to ensure fast and smooth delivery of ordered goods. Another key area in which McKesson Europe AG operates is pharmaceutical manufacturing. The company produces medications for patients and clinics. In addition, the company is also active in the online industry and operates various online shops for medications and beauty products. The company emphasizes high product quality and fast shipping. In the field of consulting and training, McKesson Europe AG supports pharmacies and clinics in optimizing their business processes and provides assistance in patient care and improving medical services. The portfolio of McKesson Europe AG is accordingly diverse and ranges from prescription and non-prescription medications to healthcare and beauty products, as well as medical devices and aids. Overall, McKesson Europe AG is a company with a long history and a wide portfolio of products and services that relies on efficient logistics and high quality and customer satisfaction. McKesson Europe ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling McKesson Europe's Return on Capital Employed (ROCE)

McKesson Europe's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing McKesson Europe's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

McKesson Europe's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in McKesson Europe’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about McKesson Europe stock

What is the ROCE (Return on Capital Employed) of McKesson Europe this year?

The ROCE of McKesson Europe is 0.02 undefined this year.

How has the ROCE (Return on Capital Employed) of McKesson Europe developed compared to the previous year?

The ROCE of McKesson Europe has increased by -50.84% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of McKesson Europe?

A high Return on Capital Employed (ROCE) indicates that McKesson Europe has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of McKesson Europe?

A low ROCE (Return on Capital Employed) can indicate that McKesson Europe has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from McKesson Europe impact the company?

An increase in the ROCE of McKesson Europe can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of McKesson Europe affect the company?

A decrease in ROCE of McKesson Europe can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of McKesson Europe?

Some factors that can affect McKesson Europe's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of McKesson Europe so important for investors?

The ROCE of McKesson Europe is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can McKesson Europe take to improve the ROCE?

To improve the ROCE, McKesson Europe can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does McKesson Europe pay?

Over the past 12 months, McKesson Europe paid a dividend of 0.83 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, McKesson Europe is expected to pay a dividend of 0.83 EUR.

What is the dividend yield of McKesson Europe?

The current dividend yield of McKesson Europe is 3.4 %.

When does McKesson Europe pay dividends?

McKesson Europe pays a quarterly dividend. This is distributed in the months of September, December, December, September.

How secure is the dividend of McKesson Europe?

McKesson Europe paid dividends every year for the past 20 years.

What is the dividend of McKesson Europe?

For the upcoming 12 months, dividends amounting to 0.83 EUR are expected. This corresponds to a dividend yield of 3.4 %.

In which sector is McKesson Europe located?

McKesson Europe is assigned to the 'Health' sector.

Wann musste ich die Aktien von McKesson Europe kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of McKesson Europe from 8/1/2022 amounting to 0.83 EUR, you needed to have the stock in your portfolio before the ex-date on 8/1/2022.

When did McKesson Europe pay the last dividend?

The last dividend was paid out on 8/1/2022.

What was the dividend of McKesson Europe in the year 2023?

In the year 2023, McKesson Europe distributed 0.83 EUR as dividends.

In which currency does McKesson Europe pay out the dividend?

The dividends of McKesson Europe are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von McKesson Europe

Our stock analysis for McKesson Europe Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of McKesson Europe Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.